China Clinical Trial Imaging Market Size & Outlook
China clinical trial imaging market, 2018-2030 (US$M)
Related Markets
China clinical trial imaging market highlights
- The China clinical trial imaging market generated a revenue of USD 47.6 million in 2023 and is expected to reach USD 86.7 million by 2030.
- The China market is expected to grow at a CAGR of 8.9% from 2024 to 2030.
- In terms of segment, project and data management was the largest revenue generating service in 2023.
- Clinical Trial Design and Consultation Services is the most lucrative service segment registering the fastest growth during the forecast period.
Clinical trial imaging market data book summary
| Market revenue in 2023 | USD 47.6 million |
| Market revenue in 2030 | USD 86.7 million |
| Growth rate | 8.9% (CAGR from 2023 to 2030) |
| Largest segment | Project and data management |
| Fastest growing segment | Clinical Trial Design and Consultation Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services, Project and Data Management |
| Key market players worldwide | Ixico, Navitas Organics, Medpace Holdings Inc, Clario, BioTelemetry, ProScan Imaging, Cardiovascular Imaging Technologies, Intrinsic Imaging, Resonance Health |
Other key industry trends
- In terms of revenue, China accounted for 4.2% of the global clinical trial imaging market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China clinical trial imaging market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 86.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Trial Imaging Market Scope
Clinical Trial Imaging Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China clinical trial imaging market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial imaging market will help companies and investors design strategic landscapes.
Project and data management was the largest segment with a revenue share of 28.78% in 2024. Horizon Databook has segmented the China clinical trial imaging market based on clinical trial design and consultation services, reading and analytical services, operational imaging services, system and technology support services, project and data management covering the revenue growth of each sub-segment from 2018 to 2030.
China clinical trial imaging market is anticipated to witness significant growth of 6.7% rate over the forecast period. China’s pharmaceutical and medical device markets are among the top three largest in the world.
The number of clinical trials has been increasing rapidly in China. The number of clinical trials registered on clinicaltrials.gov was 209,200 as of 31st December 2017. China launched 8,927 clinical trials, accounting for 4.27% of all clinical trials registered on this platform.
Reasons to subscribe to China clinical trial imaging market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China clinical trial imaging market databook
-
Our clientele includes a mix of clinical trial imaging market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China clinical trial imaging market , including forecasts for subscribers. This country databook contains high-level insights into China clinical trial imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China clinical trial imaging market size, by modality, 2018-2030 (US$M)
China Clinical Trial Imaging Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
